Invention Grant
- Patent Title: Heterocyclic molecules as apoptosis inducers
- Patent Title (中): 杂环分子作为凋亡诱导剂
-
Application No.: US14351479Application Date: 2012-10-11
-
Publication No.: US08946445B2Publication Date: 2015-02-03
- Inventor: Zhaoyin Wang
- Applicant: Nanjing Allgen Pharma Co. Ltd.
- Applicant Address: CN Nanjing
- Assignee: Nanjing Allgen Pharma Co., Ltd.
- Current Assignee: Nanjing Allgen Pharma Co., Ltd.
- Current Assignee Address: CN Nanjing
- Agency: Kilpatrick Townsend & Stockton LLP
- International Application: PCT/CA2012/000942 WO 20121011
- International Announcement: WO2013/053045 WO 20130418
- Main IPC: C07D487/02
- IPC: C07D487/02 ; C07D491/02 ; C07D495/02 ; C07D497/02 ; A61N5/10 ; A61K31/407 ; A61K31/437 ; C07D471/04 ; C07D487/04 ; C07D495/04 ; A61K45/06 ; A61K31/675
Abstract:
The present document describes novel compounds which may inhibit the activity of anti-apoptotic proteins such as Bcl-2 family protein members, compositions containing the compounds and methods of treating diseases involving a defect in apoptosis, such as, for example, in the treatment of cancer.
Public/Granted literature
- US20140256768A1 HETEROCYCLIC MOLECULES AS APOPTOSIS INDUCERS Public/Granted day:2014-09-11
Information query
